Human Longevity Extends $1M Lung Cancer Pledge with AI Detection
Company reiterates its precision prevention commitment with latest expansion of its high-stakes cancer pledge—now targeting lung cancer, the world’s deadliest cancer. In a bold move to challenge one of the deadliest cancers worldwide , Human Longevity, Inc. (HLI) is expanding its high-profile $1 million pledge to include late-stage lung cancer—sending a clear signal that precision prevention is not just a promise, but a guarantee. Reflecting HLI’s…
